This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Scotiabank analyst Allan Verkhovski initiated coverage on Paylocity Holding Corporation (NASDAQ:PCTY) with a Sector Perform rating and announced a price target of $190. Paylocity shares closed at $186.75 on Tuesday. See how other analysts view this stock.
• Chardan Capital analyst Keay Nakae initiated coverage on Korro Bio, Inc. (NASDAQ:KRRO) with a Buy rating and announced a price target of $25. Korro Bio shares closed at $13.40 on Tuesday. See how other analysts view this stock.
• Scotiabank initiated coverage on CG Oncology, Inc. (NASDAQ:CGON) with a Sector Perform rating and announced a price target of $23. CG Oncology shares closed at $20.11 on Tuesday. See how other analysts view this stock.
• Scotiabank initiated coverage on UroGen Pharma Ltd. (NASDAQ:URGN) with a Sector Outperform rating and announced a price target of $23. UroGen Pharma shares closed at $10.75 on Tuesday. See how other analysts view this stock.
• Scotiabank analyst George Farmer initiated coverage on Protara Therapeutics, Inc. (NASDAQ:TARA) with a Sector Outperform rating and announced a price target of $12. Protara Therapeutics shares closed at $4.17 on Tuesday.  See how other analysts view this stock.

Considering buying URGN stock? Here’s what analysts think:

Read This Next:

• Jim Cramer: Planet Fitness Is Doing Better Than Expected, Says No To This Industrial Stock

Photo via Shutterstock